Retinalamin — Khavinson bioregulator — retina / ophthalmology
Retinalamin is a polypeptide complex derived from bovine retina. Targets retinal tissue specifically. Restores retinal cell gene expression, promotes photoreceptor survival, reduces oxidative damage to RPE cells, and improves electroretinogram (ERG) function. Used clinically in Russia for glaucoma, age-related macular degeneration, and diabetic retinopathy. Administered as parabulbar (periocular) injection in ophthalmic settings.
نظرة عامة
هذه الصفحة جزء من مكتبة المركّبات المُصنَّفة بالأدلة في Hormonaly. جميع الادعاءات السريرية مرتبطة بمصادر علمية مُحكَّمة عبر خط أنابيب التحقق المزدوج للاستشهادات.
فئة المركّب
Khavinson bioregulator — retina / ophthalmology
آلية العمل
Retinalamin is a polypeptide complex derived from bovine retina. Targets retinal tissue specifically. Restores retinal cell gene expression, promotes photoreceptor survival, reduces oxidative damage to RPE cells, and improves electroretinogram (ERG) function. Used clinically in Russia for glaucoma, age-related macular degeneration, and diabetic retinopathy. Administered as parabulbar (periocular) injection in ophthalmic settings.
الوضع التنظيمي
Not FDA approved. Russian pharmaceutical drug (Retinalamin for injection). Approved in Russia for retinal diseases.
مستوى الأدلة
Moderate — Approved pharmaceutical drug in Russia with clinical data for multiple retinal diseases. Epitalon's n=162 RCT was for retinitis pigmentosa (different compound but related).